Title of article
Transcatheter aortic valve implantation with the CoreValve for the treatment of rheumatic aortic stenosis
Author/Authors
Bilge, Mehmet Yıldırım Beyazıt University - Faculty of Medicine - Department of Cardiology, Turkey , Bilge, Mehmet Atatürk Education and Research Hospital - Clinic of Cardiology, Turkey , Yaşar, Ayşe Saatcı Atatürk Education and Research Hospital - Clinic of Cardiology, Turkey , Alemdar, Recai Atatürk Education and Research Hospital - Clinic of Cardiology, Turkey , Ali, Sina Atatürk Education and Research Hospital - Clinic of Cardiology, Turkey
From page
296
To page
297
Abstract
Transcatheter aortic valve implantation (TAVI) is a new therapeutic option for inoperable/high risk patients with severe symptomatic calcific aortic stenosis (AS). The only admitted indication for TAVI is the treatment of patients with symptomatic severe calcific AS. However, some reports suggested feasibility and good short-term results with ‘‘off-label’’ uses of TAVI in patients with degenerated aortic bioprostheses and aortic regurgitation (1-3).
Journal title
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Journal title
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Record number
2692739
Link To Document